<DOC>
	<DOCNO>NCT03103555</DOCNO>
	<brief_summary>This pilot study aim investigate application proteosome inhibitor , Bortezomib treatment patient neutralize autoantibody IFN-γ . The investigator hypothesis bortezomib reduce antibody level restore interferon-gamma function , result clinical improvement well-tolerated safe use patient autoantibody IFN-γ .</brief_summary>
	<brief_title>Treatment Adult-Onset Immunodeficiency With Bortezomib</brief_title>
	<detailed_description>The patient autoantibody IFN-γ past current history proven opportunistic infection receive 2 treatment cycle bortezomib subcutaneously ( 4 injection 1.3 mg Bortezomib /m2 body surface per cycle ) , follow low dose oral cyclophosphamide 4 month completion treatment bortezomib .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<mesh_term>Autoantibodies</mesh_term>
	<mesh_term>Interferon-gamma</mesh_term>
	<criteria>Age 21 60 year Positive antiinterferongamma autoantibody AntiHIV negative Past current infection opportunistic infection ( OI ) nontuberculous mycobacteria , proven culture Ability give write consent , inform write consent Negative pregnancy test premenopausal woman Receving antimicrobial treatment OI least one month . Pregnancy lactation Absolute neutrophil count &lt; 1.5 × 109/ L platelet count &lt; 100× 109/ L hemoglobin level &lt; 8 g/dL Past history myocardial infarction heart failure within 6 month enrollment prolong QT interval &gt; 450 msec screen Renal insufficiency ( GFR &lt; 30 ml/min ) Abnormal liver function test ( AST &gt; 3 time UNL ) Known cancer receive immunosuppressive agent Known intolerability Bortezomib</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Anti-interferon gamma autoantibody</keyword>
</DOC>